NCT03004963View on ClinicalTrials.gov

Bioimpedance-guided Fluid Management in Chronic Peritoneal Dialysis Patients.

NACompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
End Stage Renal Disease
Interventions
DEVICE

Body composition monitor

Both body composition monitor (BCM) is used to evaluate the volume status of patients.

DEVICE

clinical indexes

The investigators evaluate the volume status of patients according to clinical indexes.

Trial Locations (1)

200127

Department of nephrology , Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT03004963 - Bioimpedance-guided Fluid Management in Chronic Peritoneal Dialysis Patients. | Biotech Hunter | Biotech Hunter